Skip to main content
. 2018 Jun 6;6(2):69. doi: 10.3390/biomedicines6020069

Table 1.

Characteristics by cancer type.

Total (n = 88 *)
Male 63 (72%)
Race Caucasian 70 (80%)
African American 5 (6%)
Asian 2 (2%)
Hispanic 3 (3%)
Unknown 8 (9%)
Stage 1 6 (7%)
2 12 (14%)
3 12 (14%)
4 58 (65%)
Chemotherapy 71 (81%)
Surgery 74 (84%)
Radiation 30 (34%)

Patient baseline clinical–pathological characteristics. * Of 93 total patients, 88 patients had detectable iCTCs.